Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: A Phase 2 Randomized Clinical Trial.

DeRubeis RJ, Zajecka J, Shelton RC, Amsterdam JD, Fawcett J, Xu C, Young PR, Gallop R, Hollon SD.

JAMA Psychiatry. 2019 Dec 4. doi: 10.1001/jamapsychiatry.2019.3900. [Epub ahead of print]

PMID:
31799993
2.

Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial.

Domany Y, Shelton RC, McCullumsmith CB.

Depress Anxiety. 2019 Nov 16. doi: 10.1002/da.22975. [Epub ahead of print]

PMID:
31733088
3.

Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial.

Thase ME, Parikh SV, Rothschild AJ, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Macaluso M, Li J, Brown K, Jablonski MR, Greden JF.

J Clin Psychiatry. 2019 Oct 31;80(6). pii: 19m12910. doi: 10.4088/JCP.19m12910.

4.

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY).

Fava M, Dirks B, Freeman MP, Papakostas GI, Shelton RC, Thase ME, Trivedi MH, Liu K, Stankovic S.

J Clin Psychiatry. 2019 Sep 24;80(6). pii: 19m12928. doi: 10.4088/JCP.19m12928.

5.

Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship.

Kamali M, Reilly-Harrington NA, Chang WC, McInnis M, McElroy SL, Ketter TA, Shelton RC, Deckersbach T, Tohen M, Kocsis JH, Calabrese JR, Gao K, Thase ME, Bowden CL, Kinrys G, Bobo WV, Brody BD, Sylvia LG, Rabideau DJ, Nierenberg AA.

J Affect Disord. 2019 Dec 1;259:164-172. doi: 10.1016/j.jad.2019.08.032. Epub 2019 Aug 19.

PMID:
31445343
6.

Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors.

Fung VC, Overhage LN, Sylvia LG, Reilly-Harrington NA, Kamali M, Gao K, Shelton RC, Ketter TA, Bobo WV, Thase ME, Calabrese JR, Tohen M, Deckersbach T, Nierenberg AA.

J Affect Disord. 2019 Oct 1;257:17-22. doi: 10.1016/j.jad.2019.06.050. Epub 2019 Jul 2.

PMID:
31299400
7.

Effect of race on the relationship between child maltreatment and obesity in Whites and Blacks.

Chieh AY, Liu Y, Gower BA, Shelton RC, Li L.

Stress. 2019 Jun 11:1-7. doi: 10.1080/10253890.2019.1625883. [Epub ahead of print]

PMID:
31184234
8.

Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials.

Köhler-Forsberg O, Sylvia LG, Bowden CL, Calabrese JR, Thase ME, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA.

Acta Neuropsychiatr. 2019 Aug;31(4):230-234. doi: 10.1017/neu.2019.19. Epub 2019 Jun 6.

PMID:
31169098
9.

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Daly EJ, Trivedi MH, Janik A, Li H, Zhang Y, Li X, Lane R, Lim P, Duca AR, Hough D, Thase ME, Zajecka J, Winokur A, Divacka I, Fagiolini A, Cubala WJ, Bitter I, Blier P, Shelton RC, Molero P, Manji H, Drevets WC, Singh JB.

JAMA Psychiatry. 2019 Jun 5. doi: 10.1001/jamapsychiatry.2019.1189. [Epub ahead of print]

10.

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.

Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB.

Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21. Erratum in: Am J Psychiatry. 2019 Aug 1;176(8):669.

PMID:
31109201
11.

Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapies.

Greden JF, Parikh SV, Rothschild AJ, Thase ME, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Macaluso M, Li J, Brown K, Gilbert A, Burns L, Jablonski MR, Dechairo B.

J Psychiatr Res. 2019 Jul;114:211-213. doi: 10.1016/j.jpsychires.2019.04.027. Epub 2019 Apr 27. No abstract available.

PMID:
31101328
12.

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.

Cavallari LH, Van Driest SL, Prows CA, Bishop JR, Limdi NA, Pratt VM, Ramsey LB, Smith DM, Tuteja S, Duong BQ, Hicks JK, Lee JC, Obeng AO, Beitelshees AL, Bell GC, Blake K, Crona DJ, Dressler L, Gregg RA, Hines LJ, Scott SA, Shelton RC, Weitzel KW, Johnson JA, Peterson JF, Empey PE, Skaar TC; IGNITE Network.

Genet Med. 2019 Oct;21(10):2255-2263. doi: 10.1038/s41436-019-0484-3. Epub 2019 Mar 21.

13.

Implementation of Clinical Practice Guidelines in the Health Care Setting: A Concept Analysis.

Beauchemin M, Cohn E, Shelton RC.

ANS Adv Nurs Sci. 2019 Oct/Dec;42(4):307-324. doi: 10.1097/ANS.0000000000000263.

PMID:
30839334
14.

Serotonin and Norepinephrine Reuptake Inhibitors.

Shelton RC.

Handb Exp Pharmacol. 2019;250:145-180. doi: 10.1007/164_2018_164.

PMID:
30838456
15.

Sustaining Evidence-Based Interventions and Policies: Recent Innovations and Future Directions in Implementation Science.

Shelton RC, Lee M.

Am J Public Health. 2019 Feb;109(S2):S132-S134. doi: 10.2105/AJPH.2018.304913. No abstract available.

16.

"You probably can't feel as safe as normal women": Hispanic women's reactions to breast density notification.

Pacsi-Sepulveda AL, Shelton RC, Rodriguez CB, Coq AT, Tehranifar P.

Cancer. 2019 Jun 15;125(12):2049-2056. doi: 10.1002/cncr.32002. Epub 2019 Feb 15.

PMID:
30768781
17.

Mixed-methods evaluation of mental healthcare integration into tuberculosis and maternal-child healthcare services of four South African districts.

Lovero KL, Lammie SL, van Zyl A, Paul SN, Ngwepe P, Mootz JJ, Carlson C, Sweetland AC, Shelton RC, Wainberg ML, Medina-Marino A.

BMC Health Serv Res. 2019 Jan 31;19(1):83. doi: 10.1186/s12913-019-3912-9.

18.

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.

Greden JF, Parikh SV, Rothschild AJ, Thase ME, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Macaluso M, Li J, Brown K, Gilbert A, Burns L, Jablonski MR, Dechairo B.

J Psychiatr Res. 2019 Apr;111:59-67. doi: 10.1016/j.jpsychires.2019.01.003. Epub 2019 Jan 4.

19.

Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.

Kinrys G, Bowden CL, Nierenberg AA, Hearing CM, Gold AK, Rabideau DJ, Sylvia LG, Gao K, Kamali M, Bobo WV, Tohen M, Deckersbach T, McElroy SL, Ketter TA, Shelton RC, Friedman ES, Calabrese JR, McInnis MG, Kocsis J, Thase ME, Singh V, Reilly-Harrington NA.

J Affect Disord. 2019 Mar 1;246:126-131. doi: 10.1016/j.jad.2018.12.039. Epub 2018 Dec 18.

PMID:
30580198
20.

Examining the external validity of the CRUZA study, a randomized trial to promote implementation of evidence-based cancer control programs by faith-based organizations.

Allen JD, Shelton RC, Kephart L, Tom LS, Leyva B, Ospino H, Cuevas AG.

Transl Behav Med. 2018 Nov 29. doi: 10.1093/tbm/iby099. [Epub ahead of print]

PMID:
30496532
21.

An orientation for new researchers to key domains, processes, and resources in implementation science.

Koh S, Lee M, Brotzman LE, Shelton RC.

Transl Behav Med. 2018 Nov 16. doi: 10.1093/tbm/iby095. [Epub ahead of print]

PMID:
30445445
22.

Use of social network analysis in the development, dissemination, implementation, and sustainability of health behavior interventions for adults: A systematic review.

Shelton RC, Lee M, Brotzman LE, Crookes DM, Jandorf L, Erwin D, Gage-Bouchard EA.

Soc Sci Med. 2019 Jan;220:81-101. doi: 10.1016/j.socscimed.2018.10.013. Epub 2018 Oct 19. Review.

PMID:
30412922
23.

Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder.

Behrendt-Møller I, Madsen T, Sørensen HJ, Sylvia L, Friedman ES, Shelton RC, Bowden CL, Calabrese JR, McElroy SL, Ketter TA, Reilly-Harrington NA, Gao K, Thase M, V Bobo W, Tohen M, McInnis M, Kamali M, Kocsis JH, Deckersbach T, Köhler-Forsberg O, Nierenberg AA.

Bipolar Disord. 2019 Jun;21(4):350-360. doi: 10.1111/bdi.12715. Epub 2018 Dec 1.

PMID:
30383333
24.

Early Exposure to Cumulative Social Risk and Trajectories of Body Mass Index in Childhood.

Liu R, Shelton RC, Eldred-Skemp N, Goldsmith J, Suglia SF.

Child Obes. 2019 Jan;15(1):48-55. doi: 10.1089/chi.2018.0116. Epub 2018 Oct 26.

PMID:
30362818
25.

2018 American Society of Consultant Pharmacists Annual Meeting & Exhibition.

Bridgeman M, Prete D, Rolston N, Abazia D, Sturgill M, Finn L, Summers D, Marvanova M, Henkel P, Thompson J, Dewey M, Friesner D, Marvanova M, Alessi C, Cuellar L, Yamagishi L, O'Neil C, Erickson O, Mazzei K, Kamal K, Early N, Bainter B, Hanson L, Schmitz E, Loomis A, Norberto M, Hume A, Meyer M, Batra R, Likar D, Enguidanos S, Liu C, Kotansky B, Fisher A, Ruby CM, Pruskowski J, Karim SNA, Yong BSW, Alessi C, Cuellar L, Slattum P, Crouse E, Delafuente J, Donohoe K, Ogbonna K, Peron E, Powers K, Price E, Zimmerman K, Rahim S, Gendron T, Slattum P, Donohoe K, Cho C, Zimmerman K, Crouse E, Peron E, Powers K, Price E, Slattum P, Donohoe K, Elliott L, Minter C, Morin M, Marshall L, Stevens G, Cordaro C, Hill M, Nagy K, Kroustos KR, Sobota KF, Mahan R, Bailey T, Ioannou K, Mansour D, Thompson T, Chatellier K, Schwenk A, Ruby C, Chen TS, Li S, James M, Spilios M, Leschak A, Levine A, Forgette S, Oluigbo N, Szollosi D, Avalime D, Weaver SB, Maneno M, Ettienne E, Yi JY, Hart L, Gray S, Ozalas S, Miller K, Dave R, Bork J, Emmelhainz J, Adams K, Postolski J, Willoughby M, Feldman E, Braham K, Miller C, Barbagallo D, Seabury R, Noviasky J, Alessi C, Cuellar L, Dabhi J, Bartlett D, Le T, Simoni-Wastila L, Kuzucan A, Simoni-Wastila L, Le T, Park S, Simoni-Wastila L, Le T, Park S, Choi M, Simoni-Wastila L, Park S, Le T, Choi M, Simoni-Wastila L, Khokhar B, Choi M, Le T, Simoni-Wastila L, Brody P, Hejna M, Mason J, Graham M, Micceri J, Lypska R, Quinn B, Wilson H, Wahler R, Aloyo M, Tomm V, Hill A, Obringer A, Butterfoss K, Blak J, Balcer R, Boza J, Foster A, Shafique E, Kleven C, Wigle P, Brown B, Alessi C, Cuellar L, Meyer K, Mobley-Bukstein W, Singh H, Perez E, Mira AE, Kuehner W, Czechowski L, Cook H, Brandt N, Parson J, Fornaro R, Brandt N, Claeys K, Zarowitz B, Mansour D, McFadden C, Simpkins S, Ojowa F, Klutts A, Holmes S, Smith E, Cornman JR, Doran K, Resnick B, Brandt N, Umeozulu C, Williams A, Brandt N, Hennawi G, Thomas D, Gerber DK, Meyer K, Sharma K, Cooke C, Howard A, Chater R, Vogler A, Brandt N, Kennett-Hayes K, Elliott L, Engelbert J, Hargrave E, Bambico C, Patel K, Warriner C, Slattum P, Desai NR, Rowan CG, Alvarez P, Fogli J, Toto RD, Desai NR, Alvarez P, Fogli J, Reed P, Owens MK, Greden JF, Rothschild AJ, Zandy S, Thase M, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Li J, Gilbert A, Burns L, Jablonski M, Dechairo B, Parikh S, Donohue J, Feldman G, Sethi S, Barnes C, Pendyala S, Bourdet D, Ferguson G, Barnes C, Pendyala S, Crater G, Fogli J, Mayo M, Gross C, Miyawa J, Ono R, Woods S, Garza D, Panov N, Fogli J, Moran E, Sabesan V, Wertman J, Ngim K.

Consult Pharm. 2017 Oct 1;33(10):572-608.

PMID:
30322434
26.

Decision-making under clinical uncertainty: An in-depth examination of provider perspectives on adjuvant chemotherapy for stage II colon cancer.

Shelton RC, Brotzman LE, Crookes DM, Robles P, Neugut AI.

Patient Educ Couns. 2019 Feb;102(2):284-290. doi: 10.1016/j.pec.2018.09.015. Epub 2018 Sep 17.

PMID:
30262401
27.

The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study.

Yaramala SR, McElroy SL, Geske J, Winham S, Gao K, Reilly-Harrington NA, Ketter TA, Deckersbach T, Kinrys G, Kamali M, Sylvia LG, McInnis MG, Friedman ES, Thase ME, Kocsis JH, Tohen M, Calabrese JR, Bowden CL, Shelton RC, Nierenberg AA, Bobo WV.

J Affect Disord. 2018 Sep 12. pii: S0165-0327(18)30069-7. doi: 10.1016/j.jad.2018.09.025. [Epub ahead of print]

PMID:
30241956
28.

Study Design and Use of Inquiry Frameworks in Qualitative Research Published in Health Education & Behavior.

Kegler MC, Raskind IG, Comeau DL, Griffith DM, Cooper HLF, Shelton RC.

Health Educ Behav. 2019 Feb;46(1):24-31. doi: 10.1177/1090198118795018. Epub 2018 Sep 18.

PMID:
30227081
29.

A Review of Qualitative Data Analysis Practices in Health Education and Health Behavior Research.

Raskind IG, Shelton RC, Comeau DL, Cooper HLF, Griffith DM, Kegler MC.

Health Educ Behav. 2019 Feb;46(1):32-39. doi: 10.1177/1090198118795019. Epub 2018 Sep 18.

PMID:
30227078
30.

Development of tailored feedback reports on organizational capacity for health promotion in African American churches.

Holt CL, Shelton RC, Allen JD, Bowie J, Jandorf L, Zara Santos SL, Slade J.

Eval Program Plann. 2018 Oct;70:99-106. doi: 10.1016/j.evalprogplan.2018.07.002. Epub 2018 Jul 21.

31.

Major Depressive Disorder Following Dermatomyositis: A Case Linking Depression with Inflammation.

Reddy A, Birur B, Shelton RC, Li L.

Psychopharmacol Bull. 2018 Mar 13;48(3):22-28.

32.

Future Perfect? The Future of the Social Sciences in Public Health.

Shelton RC, Hatzenbuehler ML, Bayer R, Metsch LR.

Front Public Health. 2018 Jan 10;5:357. doi: 10.3389/fpubh.2017.00357. eCollection 2017.

33.

Role of Complex Epigenetic Switching in Tumor Necrosis Factor-α Upregulation in the Prefrontal Cortex of Suicide Subjects.

Wang Q, Roy B, Turecki G, Shelton RC, Dwivedi Y.

Am J Psychiatry. 2018 Mar 1;175(3):262-274. doi: 10.1176/appi.ajp.2017.16070759. Epub 2018 Jan 24.

34.

Treatment outcomes of acute bipolar depressive episode with psychosis.

Caldieraro MA, Dufour S, Sylvia LG, Gao K, Ketter TA, Bobo WV, Walsh S, Janos J, Tohen M, Reilly-Harrington NA, McElroy SL, Shelton RC, Bowden CL, Deckersbach T, Nierenberg AA.

Depress Anxiety. 2018 May;35(5):402-410. doi: 10.1002/da.22716. Epub 2018 Jan 12.

PMID:
29329498
35.

The Sustainability of Evidence-Based Interventions and Practices in Public Health and Health Care.

Shelton RC, Cooper BR, Stirman SW.

Annu Rev Public Health. 2018 Apr 1;39:55-76. doi: 10.1146/annurev-publhealth-040617-014731. Epub 2018 Jan 12. Review.

PMID:
29328872
36.

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.

Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, Thase ME, Winokur A, Van Nueten L, Manji H, Drevets WC.

JAMA Psychiatry. 2018 Feb 1;75(2):139-148. doi: 10.1001/jamapsychiatry.2017.3739.

37.

Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder.

Köhler-Forsberg O, Sylvia L, Deckersbach T, Ostacher MJ, McInnis M, Iosifescu D, Bowden C, McElroy S, Calabrese J, Thase M, Shelton RC, Tohen M, Kocsis J, Friedman E, Ketter T, Nierenberg AA.

Acta Neuropsychiatr. 2018 Oct;30(5):297-305. doi: 10.1017/neu.2017.34. Epub 2017 Dec 7.

PMID:
29212563
38.
39.

Gender-Specific Relationship between Obesity and Major Depression.

Li L, Gower BA, Shelton RC, Wu X.

Front Endocrinol (Lausanne). 2017 Nov 10;8:292. doi: 10.3389/fendo.2017.00292. eCollection 2017.

40.

Response to: Commentary: Sex Differences in the Peripheral Immune System in Patients with Depression.

Birur B, Shelton RC, Amrock EM, Li L.

Front Psychiatry. 2017 Nov 10;8:231. doi: 10.3389/fpsyt.2017.00231. eCollection 2017. No abstract available.

41.

Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression.

Caldieraro MA, Walsh S, Deckersbach T, Bobo WV, Gao K, Ketter TA, Shelton RC, Reilly-Harrington NA, Tohen M, Calabrese JR, Thase ME, Kocsis JH, Sylvia LG, Nierenberg AA.

Aust N Z J Psychiatry. 2018 Oct;52(10):994-1002. doi: 10.1177/0004867417741982. Epub 2017 Nov 16.

PMID:
29143534
42.

Extending Our Reach for Greater Impact.

Bennett GG, Shelton RC.

Health Educ Behav. 2017 Dec;44(6):835-838. doi: 10.1177/1090198117736354. Epub 2017 Oct 12. No abstract available.

PMID:
29025265
43.

Sex differences in the association between perceived stress and adiposity in a nationally representative sample.

Suglia SF, Pamplin JR 2nd, Forde AT, Shelton RC.

Ann Epidemiol. 2017 Oct;27(10):626-631. doi: 10.1016/j.annepidem.2017.09.009. Epub 2017 Sep 21.

44.

The Promise of Qualitative Research to Inform Theory to Address Health Equity.

Shelton RC, Griffith DM, Kegler MC.

Health Educ Behav. 2017 Oct;44(5):815-819. doi: 10.1177/1090198117728548.

PMID:
28927355
45.

Advancing the Science of Qualitative Research to Promote Health Equity.

Griffith DM, Shelton RC, Kegler M.

Health Educ Behav. 2017 Oct;44(5):673-676. doi: 10.1177/1090198117728549.

PMID:
28927354
46.

Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.

Sylvia LG, Chang WC, Kamali M, Tohen M, Kinrys G, Deckersbach T, Calabrese JR, Thase ME, Reilly-Harrington N, Bobo WV, Kocsis JH, McInnis MG, Bowden CL, Ketter TA, Friedman ES, Shelton RC, McElroy SL, Gao K, Rabideau DJ, Nierenberg AA.

J Affect Disord. 2018 Jan 1;225:563-568. doi: 10.1016/j.jad.2017.08.056. Epub 2017 Aug 19.

PMID:
28881294
47.

Interaction between early-life stress and FKBP5 gene variants in major depressive disorder and post-traumatic stress disorder: A systematic review and meta-analysis.

Wang Q, Shelton RC, Dwivedi Y.

J Affect Disord. 2018 Jan 1;225:422-428. doi: 10.1016/j.jad.2017.08.066. Epub 2017 Aug 24. Review.

48.

Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189].

Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG.

J Affect Disord. 2018 Jan 1;225:775-777. doi: 10.1016/j.jad.2017.08.032. Epub 2017 Aug 18. No abstract available.

PMID:
28826887
49.

Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder.

Köhler-Forsberg O, Madsen T, Behrendt-Møller I, Sylvia L, Bowden CL, Gao K, Bobo WV, Trivedi MH, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Ketter TA, Friedman ES, Deckersbach T, McElroy SL, Reilly-Harrington NA, Nierenberg AA.

J Affect Disord. 2017 Dec 1;223:146-152. doi: 10.1016/j.jad.2017.07.038. Epub 2017 Jul 20.

PMID:
28755622
50.

Efficacy of Ziprasidone Augmentation of Escitalopram for Cognitive Symptoms of Major Depressive Disorder.

Iovieno N, Shelton RC, Petrie SR, Cusin C, Fava M, Papakostas GI.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 16m10920. doi: 10.4088/JCP.16m10920.

PMID:
28749091

Supplemental Content

Loading ...
Support Center